Brown Brothers Harriman & Co’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.71K | Sell |
66
-1
| -1% | -$26 | ﹤0.01% | 1446 |
|
|
2025
Q1 | $680 | Hold |
67
| – | – | ﹤0.01% | 1267 |
|
|
2024
Q4 | $930 | Hold |
67
| – | – | ﹤0.01% | 1380 |
|
|
2024
Q3 | $1.3K | Sell |
67
-20
| -23% | -$388 | ﹤0.01% | 1341 |
|
|
2024
Q2 | $1.61K | Sell |
87
-103
| -54% | -$1.91K | ﹤0.01% | 1085 |
|
|
2024
Q1 | $2.66K | Hold |
190
| – | – | ﹤0.01% | 1078 |
|
|
2023
Q4 | $1.61K | Hold |
190
| – | – | ﹤0.01% | 1073 |
|
|
2023
Q3 | $1.7K | Hold |
190
| – | – | ﹤0.01% | 1120 |
|
|
2023
Q2 | $1.64K | Hold |
190
| – | – | ﹤0.01% | 1146 |
|
|
2023
Q1 | $2K | Hold |
190
| – | – | ﹤0.01% | 1156 |
|
|
2022
Q4 | $6.44K | Hold |
190
| – | – | ﹤0.01% | 1075 |
|
|
2022
Q3 | $9K | Hold |
190
| – | – | ﹤0.01% | 1178 |
|
|
2022
Q2 | $11K | Hold |
190
| – | – | ﹤0.01% | 995 |
|
|
2022
Q1 | $15K | Hold |
190
| – | – | ﹤0.01% | 971 |
|
|
2021
Q4 | $39 | Hold |
190
| – | – | ﹤0.01% | 747 |
|
|
2021
Q3 | $51 | Hold |
190
| – | – | ﹤0.01% | 676 |
|
|
2021
Q2 | $49 | Hold |
190
| – | – | ﹤0.01% | 672 |
|
|
2021
Q1 | $57 | Hold |
190
| – | – | ﹤0.01% | 622 |
|
|
2020
Q4 | $48K | Hold |
190
| – | – | ﹤0.01% | 669 |
|
|
2020
Q3 | $47K | Hold |
190
| – | – | ﹤0.01% | 581 |
|
|
2020
Q2 | $66K | Hold |
190
| – | – | ﹤0.01% | 542 |
|
|
2020
Q1 | $51K | Hold |
190
| – | – | ﹤0.01% | 534 |
|
|
2019
Q4 | $62K | Sell |
190
-2
| -1% | -$653 | ﹤0.01% | 630 |
|
|
2019
Q3 | $53K | Buy |
192
+2
| +1% | +$552 | ﹤0.01% | 636 |
|
|
2019
Q2 | $101K | Buy |
+190
| New | +$101K | ﹤0.01% | 486 |
|